Skip to main content
SpringerLink
Log in

Comparative extrapyramidal effects of Rauwolfia vomitoria, chlorpromazine and reserpine in mice

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Most antipsychotics interfere with the dopaminergic system, resulting in extrapyramidal effects. This study compared the extrapyramidal effects of chlorpromazine (Cpz), the herb Rauwolfia vomitoria (RV) and its alkaloid reserpine (Res), used as antipsychotics, in mice. Ninety age-matched male CD-1 strain of mice (25–33 g body weight) were divided into 3 groups, each consisting of 5 subgroups (n = 6). Cpz (0.0, 0.25, 1.0, 2.0 and 4.0 mg/kg, i.p.) was administered 30 min before testing. RV (0.0, 0.25, 1.0, 2.0 and 4.0 mg/kg, i.p.) and Res (0.0, 0.1, 0.4, 0.8, 1.6 mg/kg, i.p.) were administered 24 h before testing. Locomotor behaviour (open field test) and motor coordination (acceleratory rotarod) were assessed. Mice were also observed for 10 min for tremor and vacuous chewing movement (VCM). CPZ and Res dose-dependently decreased locomotor behaviour and impaired motor coordination (p < 0.01). RV also decreased locomotor behaviour (4.0 mg/kg; p < 0.05) but had minimal effect on motor coordination. VCM was lower in the RV group (0.17 ± 0.16/10 min) than the Res (6.8 ± 1.36/10 min) and Cpz groups (7.83 ± 1.95/10 min): F (4,25) = 10.703; p < 0.01. The frequency of bouts of tremor was also lower in the RV group (1.17 ± 0.72/10 min) than the Res (21.2 ± 5.63/10 min) and Cpz (7.83 ± 1.59/10 min) groups: F (4,25) = 11.012; p < 0.001. The root bark extract of R. vomitoria, therefore, has great potential in the management of psychotic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Swett C Jr, Cole JO, Shapiro S, Slone D (1977) Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis. Arch Gen Psychiatry 34(8):942–943

    Article  PubMed  Google Scholar 

  2. Patterson BD, Swingler D, Willows S (2005) Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa. Schizophr Res 76:89–97

    Article  PubMed  Google Scholar 

  3. Bishnoi M, Kumar A, Chopra K, Kulkarni SK (2007) Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Indian J Exp Biol 45(2):175–179

    PubMed  CAS  Google Scholar 

  4. Llorca PM, Chereau I, Bayle FJ, Lancon C (2002) Tardive dyskinesias and antipsychotics: a review. Eur Psychiatry 17(3):129–138

    Article  PubMed  Google Scholar 

  5. Wang PS, Schneeweiss S, Avorn J (2005) Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 353(22):2335–2341

    Article  PubMed  CAS  Google Scholar 

  6. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW (1995) Antipsychotic agents antagonize non-competitive N-methyl D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67–77

    Article  PubMed  CAS  Google Scholar 

  7. Hardman JG, Limbird LE, Gilman AG (2001) Drugs and the treatment of psychiatric disorders: the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York

    Google Scholar 

  8. Remington G (2003) Understanding antipsychotic “atypicality”: a clinical and pharmacological moving target. J Psychiatry Neurosci 28(4):275–284

    PubMed  Google Scholar 

  9. Peirre JM (2005) Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management. Drug Saf 28:191–208

    Article  Google Scholar 

  10. Chong MY, Tan CH, Fujii S, Yang S, Ungvari GS, Si T, Chung EK, Sim K, Tsang HY, Shinfuku N (2004) Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry Clin Neurosci 58:61–67

    Article  PubMed  Google Scholar 

  11. World Health Organization (WHO) (2003). Essential medicines, 13th edn. WHO model list. http://www.who.int/hac/techguidance/pht/essentialmed/en. Retrieved 23 Oct 2007

  12. Makanjuola ROA (1987) Yoruba traditional healer in psychiatry. Healers’ concept of the nature and aetiology of mental disorders. Afr J Med Med Sci 16:53–59

    PubMed  CAS  Google Scholar 

  13. Gureje O, Acha RA, Odejide OA (1995) Pathways to psychiatric care in Ibadan, Nigeria. Trop Geogr Med 47:125–129

    PubMed  CAS  Google Scholar 

  14. Kanba S, Yamada K, Mizushima H, Asai M (1998) Use of herbal medicine for treating psychiatric disorders in Japan. Psychiatry Clin Neurosci 52:331–333

    Google Scholar 

  15. Unützer J, Klap R, Sturm R, Young AS, Marmon T, Shatkin J, Wells KB (2000) Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry 157:1851–1857

    Article  PubMed  Google Scholar 

  16. Akpanabiatu MI, Umoh IB, Eyong EU (2006) Influence of Rauwolfia vomitoria root bark on cardiac enzymes of normal Wistar albino rats. Recent Progr Med Plants 14:273–278

    Google Scholar 

  17. Kweifio-Okai G, Bird D, Field B, Ambrose R, Carol AR, Smith P, Valdes R (1995) Anti-inflammatory activity of a Ghanaian antiarthritic herbal preparation: III. J Ethnopharmacol 46:7–15

    Article  PubMed  CAS  Google Scholar 

  18. Amole OO, Onabanjo AO (1999) Reserpine: the effect and uses of Rauwolfia vomitoria. J Chemother 3:45–47

    Google Scholar 

  19. Campbell JIA, Mortensen A, Molgaard P (2006) Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foliage and Citrus aurantium fruit. J Ethnopharmacol 104:379–386

    Article  PubMed  Google Scholar 

  20. Bemis DL, Capodice JL, Gorroocurn P, Katz AE, Buttyan R (2006) Anti-prostate cancer activity of β-carboline alkaloid enriched extract from Rauwolfia vomitoria. Int J Oncol 29:1065–1073

    PubMed  CAS  Google Scholar 

  21. Bisong SA, Akpanabiatu MI, Osim EE (2006) The effect of crude root extract of Rauwolfia vomitoria on learning and memory in mice. Recent Progr Med Plants 22:153–162

    Google Scholar 

  22. Amole OO, Yemitan OK, Oshikoya KA (2009) Anticonvulsant activity of Rauvolfia Vomitoria (Afzel). Afr J Pharmacy Pharmacol 3(6):319–322

    Google Scholar 

  23. López-Muñoz F, Alamo C, Cuenca E, Shen WW, Clervoy P, Rubio G (2005) History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry 17(3):113–135

    Article  PubMed  Google Scholar 

  24. Aminoff MJ (2004) Pharmacologic management of Parkinsonism and other movement disorders. In: Katzung BG (ed) Basic and clinical pharmacology, 9th edn. McGraw-Hill, Singapore, pp 447–461

    Google Scholar 

  25. Giachetti A, Shore PA (1978) The reserpine receptor. Life Sci 23(2):89–92

    Article  PubMed  CAS  Google Scholar 

  26. Isharwel S, Gupta S (2006) Rustmon Jal Vakil. His contributions to cardiology. Texax Heart Inst J 33(2):161–170

    Google Scholar 

  27. Klyushnichenko VE, Yakimov SA, Tuzova TP, Syagailo YV, Kuzovkina IN, Wulfson AN, Miroshnikov AI (1995) Determination of indole alkaloids from R. serpentina and R. vomitoria by high-performance liquid chromatography and high-performance thin-layer chromatography. J Chromatogr 704:357–362

    Article  CAS  Google Scholar 

  28. Brown RE, Corey SC, Moore AK (1999) Differences in measures of exploration and fear in MHC-congenic C57BL/6J and B6-H-2K mice. Behav Genet 26:263–271

    Article  Google Scholar 

  29. Caston J, Devulder B, Jouen F, Lalonde R (1999) Role of an enriched environment on the restoration of behavioral deficits in Lurcher mutant mice. Dev Psychobiol 35:291–303

    Article  PubMed  CAS  Google Scholar 

  30. Seibt KJ, Oliveira Rda L, Zimmermann FF, Capiotti KM, Bogo MR, Ghisleni G, Bonan CD (2010) Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behav Brain Res. 25;214(2):417–422

    Google Scholar 

  31. Naidu PS, Kulkarni SK (2002) Reversal of reserpine-induced vacuous chewing movements by ethanol: possible GABA-A receptor modulation. Brain Pharmacol 1:189–195

    Google Scholar 

  32. Casey DE (2000) Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiatry 61:5–9

    PubMed  CAS  Google Scholar 

  33. Andreassen OA, Jorgessen HA (2000) Neurotoxicity associated with neuroleptic induced oral dyskinesias in rats implications for tardive dyskinesia? Prog Neurobiol 61:525–541

    Article  PubMed  CAS  Google Scholar 

  34. Miwa H (2007) Rodent models of tremor. Cerebellum 6(1):66–72

    Article  PubMed  CAS  Google Scholar 

  35. Oyewole OI, Massaquoi HO (2008) Oral administration of Rauwolfia vomitoria extract has no untoward effect on kidney and liver functions in rats. Afr J Biotechnol 7(10):1577–1580

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, College of Medical Sciences, University of Calabar, Calabar, PMB 1115, Nigeria

    Sunday Agba Bisong & Eme Effiom Osim

  2. Department of Psychology and Neuroscience, Dalhousie University, Life Science Building, Halifax, NS, B3H 4R2, Canada

    Sunday Agba Bisong & Richard Earl Brown

Authors
  1. Sunday Agba Bisong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard Earl Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eme Effiom Osim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunday Agba Bisong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bisong, S.A., Brown, R.E. & Osim, E.E. Comparative extrapyramidal effects of Rauwolfia vomitoria, chlorpromazine and reserpine in mice. J Nat Med 67, 107–112 (2013). https://doi.org/10.1007/s11418-012-0657-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-012-0657-8

Keywords

Search

Navigation